Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|October 17, 2011

vRad Announces Clinical Trials Partnership With ICON Medical Imaging

Virtual Radiologic

(vRad), a technology-enabled national radiology practice, has announced a premier radiology partnership with

ICON Medical Imaging

(ICON), the medical imaging division of ICON plc.

ICON Medical Imaging provides medical imaging-based product development services to the pharmaceutical biotechnology and medical device industries. The partnership with vRad will enable ICON Medical Imaging to access the breadth and depth of vRad's subspecialty expertise and to obtain high-quality interpretations provided by vRad's fellowship-trained radiologists.

The first clinical trial involving vRad launched in September, with more expected to rapidly follow. This partnership will provide a great opportunity for vRad radiologists to make an impact on advancing healthcare. The use of imaging in clinical trials has been recognized by the pharmaceutical industry to assist in measuring early results, thereby helping to shorten the timeline for bringing effective drugs to market, and saving costs and lives in the process.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.